Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.431EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.431NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.431NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.431NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.431NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.168EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.168NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.168NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.168NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.168NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Q.6 (Alpha)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Q.6 (Alpha)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Q.6 (Alpha)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
Q.6 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.6 (Alpha)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-2113.71Japan
AZ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AZ.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AZ.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.97EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.97NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.97NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.97NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.97NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.36.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.18NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.36.18NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.36.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.18NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.32NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.177.32NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.177.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.32NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.59EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.59NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.59NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-3342.44Germany
B.1.1.59NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.1.59NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.67EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.67NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.177.67NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.177.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.67NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
DN.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DN.1.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DN.1.1.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
DN.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used